Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 23 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

30%

7 trials in Phase 3/4

Results Transparency

20%

3 of 15 completed trials have results

Key Signals

4 recruiting3 with results

Enrollment Performance

Analytics

N/A
6(35.3%)
Phase 4
4(23.5%)
Phase 2
4(23.5%)
Phase 3
3(17.6%)
17Total
N/A(6)
Phase 4(4)
Phase 2(4)
Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT02433795Phase 2Completed

Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)

Role: collaborator

NCT06519162Recruiting

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

Role: collaborator

NCT04214210Not ApplicableRecruiting

The DIALOGUE Study: Swiss-Korean Billateral Collaboration

Role: collaborator

NCT05629728Not ApplicableRecruiting

Tai Chi for Improving Functions of Frail Older Adults

Role: lead

NCT05653596Not ApplicableRecruiting

VR-based Intervention for Cognitive Restoration

Role: lead

NCT05911711Unknown

Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients

Role: collaborator

NCT05629650Not ApplicableCompleted

Feasibility Study of Tai Chi for Cognitively Impaired Older Adults

Role: lead

NCT04734613Not ApplicableCompleted

Tai Chi for Behavioral Modification Among Individuals With Metabolic Syndrome

Role: lead

NCT00922480Phase 3Completed

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

Role: collaborator

NCT02868840Not ApplicableCompleted

Tai Chi for Stroke Rehabilitation on Balance and Cognition

Role: lead

NCT01518998Phase 2Completed

A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension

Role: collaborator

NCT00863018Completed

Corneal Endothelium After Glaucoma Surgery

Role: lead

NCT02152306Phase 3Completed

Fimasartan/Amlodipine Combination Phase III

Role: collaborator

NCT01378104Phase 4Completed

100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)

Role: collaborator

NCT01716611Phase 4Unknown

Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites

Role: collaborator

NCT01671683Completed

Additional Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer

Role: lead

NCT01645748Phase 2Completed

Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer

Role: collaborator

NCT01365572Phase 4Unknown

New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )

Role: collaborator

NCT01037842Phase 3Completed

Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus

Role: collaborator

NCT01025024Completed

Investigation of Genetic Disease Marker Associated With Korean Glaucoma Patients

Role: lead